Gland Pharma Limited has informed the Exchange regarding a press release dated July 23, 2024, titled "Gland Pharma receives Tentative Approval from the USFDA for Latanoprostene Bunod Ophthalmic Solution ".
Gland Pharma Limited has informed the Exchange regarding a press release dated July 23, 2024, titled "Gland Pharma receives Tentative Approval from the USFDA for Latanoprostene Bunod Ophthalmic Solution ".